Citation Impact
Citing Papers
Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2–Driven VHL −/− Renal Cancer
2005
Distinct fibroblast lineages determine dermal architecture in skin development and repair
2013 StandoutNature
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
1994
Mechanism of activation of the TGF-β receptor
1994 StandoutNature
Inflammation and cancer
2002 StandoutNature
Transforming growth factor β1 is implicated in the failure of tamoxifen therapy in human breast cancer
1991
Tumor Eradication by Adoptive Transfer of Cytototic T Lymphocytes
1992
Growth factors and oncogenes in breast cancer
1990
Chemokines: agents for the immunotherapy of cancer?
2002
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
1993
Changing potency by spontaneous fusion
2002 StandoutNature
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
TGF-β signalling from cell membrane to nucleus through SMAD proteins
1997 StandoutNature
The Cold Shock Domain Protein LIN-28 Controls Developmental Timing in C. elegans and Is Regulated by the lin-4 RNA
1997 StandoutNobel
The biology and function of fibroblasts in cancer
2016 Standout
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
1996 StandoutNature
Involvement of chemokine receptors in breast cancer metastasis
2001 StandoutNature
Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene Transduction
1990
The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunity
1997
Human tumor antigens recognized by T-cells
1997
The Hallmarks of Cancer
2000 Standout
The AID enzyme induces class switch recombination in fibroblasts
2002 StandoutNatureNobel
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
1993
Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.
1992
A High Affinity Binding Site for the HIV-1 Nucleocapsid Protein
1997 StandoutNobel
The molecular biology of breast cancer
1991
Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
1994 StandoutNature
Lymphokines and the immune response: the central role of interleukin-2
1991
Bidirectional regulation of macrophage function by TGF-β
1999
Chemokines and their role in tumor growth and metastasis
1998
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
Cell-mediated cytotoxicity
1993 StandoutNobel
Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis
1993
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Human breast carcinoma desmoplasia is PDGF initiated
2000
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
1992 StandoutNature
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
1992
Fibroblasts in cancer
2006 Standout
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Cancer-related inflammation
2008 StandoutNature
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Mechanisms of normal and malignant breast epithelial growth regulation
1989
Heterotypic Signaling between Epithelial Tumor Cells and Fibroblasts in Carcinoma Formation
2001
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
1998
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Multilineage Potential of Adult Human Mesenchymal Stem Cells
1999 StandoutScience
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Regulatory T Cell Clones Induced by Oral Tolerance: Suppression of Autoimmune Encephalomyelitis
1994 StandoutScience
TGFβ1 Inhibits the Formation of Benign Skin Tumors, but Enhances Progression to Invasive Spindle Carcinomas in Transgenic Mice
1996
A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.
1992
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo.
1992 StandoutNobel
Platelet-derived growth factor: mechanism of action and possible in vivo function.
1990
Mammalian Neural Stem Cells
2000 StandoutScience
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
1991 StandoutScience
CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma
1998 StandoutNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain.
1993
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA − Immunodeficient Patients
1995 Science
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
1992
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
2000 StandoutScience
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
1993 Standout
The future of cloning
1999 StandoutNatureNobel
Neutralising antibody to TGF-β1,2 reduces cutaneous scarring in adult rodents
1994
Estrogens, antiestrogens and cell proliferation
1989
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
A dominant positive and negative selectable gene for use in mammalian cells.
1991 StandoutNobel
Interleukin 6: A Multifunctional Cytokine Regulating Immune Reactions and the Acute Phase Protein Response
1990
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
1990 StandoutScience
Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.
1998
Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences.
1990
Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma Cells
1993 StandoutScienceNobel
Growth Factors and Cancer
1991 StandoutScience
Fibroblast heterogeneity in the cancer wound
2014
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Dominant Positive and Negative Selection Using a Hygromycin Phosphotransferase-Thymidine Kinase Fusion Gene
1991
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma
2018
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Derivation of pluripotent stem cells from cultured human primordial germ cells
1998
Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
1998
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
1996 StandoutScience
Tumorigenicity of mouse thymoma is suppressed by soluble type II transforming growth factor beta receptor therapy.
1999
Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
1993
Enhancement of Antitumor Immunity by CTLA-4 Blockade
1996 StandoutScienceNobel
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
1994 StandoutScience
TGF-β and cancer
2005
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Immunosuppressive Factors: Role in Cancer Development and Progression
1998
kat: a high-efficiency retroviral transduction system for primary human T lymphocytes
1994
Activation of fibroblasts in cancer stroma
2010
Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy
1994
Works of A Kasid being referenced
Expression of mRNA for Transforming Growth Factors-α and -β and Secretion of Transforming Growth Factor-β by Renal Cell Carcinoma Cell Lines
1989
Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients.
1989
Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.
1989
Lymphocytes as cellular vehicles for gene therapy in mouse and man.
1991
Transcriptional control of thymidine kinase gene expression by estrogen and antiestrogens in MCF-7 human breast cancer cells.
1986
Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene.
1987
Human gene transfer: characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man.
1990
Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.
1987
Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
1988
Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for immunotherapeutic failures.
1990
Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors
1991
Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor-beta.
1990
Effect of v-rasH oncogene transfection on estrogen-independent tumorigenicity of estrogen-dependent human breast cancer cells.
1987